An NSAID
Related Products
Labeled Version(s)
30745Etofenamate-d4
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Etofenamate

Item No. 23674

Technical Information
Formal Name
2-[[3-(trifluoromethyl)phenyl]amino]-benzoic acid, 2-(2-hydroxyethoxy)ethyl ester
CAS Number
30544-47-9
Molecular Formula
C18H18F3NO4
Formula Weight
Purity
≥98%
Formulation
A neat oil
DMF: 40 mg/mlDMSO: 40 mg/mlEthanol: 50 mg/mlEthanol:PBS(pH 7.2) (1:5): 0.1 mg/ml
λmax
205, 221, 287, 347 nm
SMILES
O=C(OCCOCCO)C1=C(NC2=CC=CC(C(F)(F)F)=C2)C=CC=C1
InChi Code
InChI=1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2
InChi Key
XILVEPYQJIOVNB-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Etofenamate is a non-steroidal anti-inflammatory drug (NSAID) and diethylene glycol ester form of flufenamic acid (Item No. 21447) that has anti-inflammatory and analgesic activities.1,2 It inhibits lipoxygenase isolated from guinea pig leukocytes (IC50 = 5.3 μM) and the production of prostaglandin E2 (PGE2; Item No. 14010) in stimulated rat peritoneal macrophages.2 In vivo, etofenamate reduces acetic acid-induced vascular permeability in mice and UV-induced erythema in guinea pigs in a dose-dependent manner at doses ranging from 40-320 and 5-20 mg/kg, respectively.1 Etofenamate (40 mg/kg per day for 21 days) inhibits inflammation in a rat model of adjuvant-induced arthritis. It also decreases the pain response in a silver nitrate-induced rat model of arthritis and the acetic acid-induced writhing test in mice, indicating analgesic activity. Formulations containing etofenamate have been used in the treatment of osteoarthritis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nakamura, H., Motoyoshi, S., Imazu, C., et alAnti-inflammatory, analgesic and anti-pyretic activities of a non-steroidal anti-inflammatory drug, etofenamate, in experimental animals. Nihon Yakurigaku Zasshi. 80(2), 125-135 (1982).

    2. Nakamura, H., Motoyoshi, S., Ishii, K., et alThe mode of anti-inflammatory action of a topical non-steroidal anti-inflammatory drug, etofenamate. Nihon Yakurigaku Zasshi. 89(1), 15-24 (1987).